COVID-19 vaccination rates in hospitalized mentally ill patients compared to the general population in Germany: Results from the COVID Ψ Vac study.


Journal

European psychiatry : the journal of the Association of European Psychiatrists
ISSN: 1778-3585
Titre abrégé: Eur Psychiatry
Pays: England
ID NLM: 9111820

Informations de publication

Date de publication:
28 Jun 2022
Historique:
pubmed: 29 6 2022
medline: 16 7 2022
entrez: 28 6 2022
Statut: epublish

Résumé

Mental illness is known to come along with a large mortality gap compared to thegeneral population and it is a risk for COVID-19 related morbidity andmortality. Achieving high vaccination rates in people with mental illness is therefore important. Reports are conflicting on whether vaccination rates comparable to those of the general population can be achieved and which variables represent risk factors for nonvaccination in people with mental illness. The COVID Ψ Vac study collected routine data on vaccination status, diagnostic groups, sociodemographics, and setting characteristics from in- and day-clinic patients of 10 psychiatric hospitals in Germany in August 2021. Logistic regression modeling was used to determine risk factors for nonvaccination. Complete vaccination rates were 59% ( Vaccination rates were lower in hospitalized people with mental illness than in the general population. By targeting at-risk groups with low-threshold vaccination programs in all health institutions they get in contact with, vaccination rates comparable to those in the general population can be achieved.

Sections du résumé

BACKGROUND
Mental illness is known to come along with a large mortality gap compared to thegeneral population and it is a risk for COVID-19 related morbidity andmortality. Achieving high vaccination rates in people with mental illness is therefore important. Reports are conflicting on whether vaccination rates comparable to those of the general population can be achieved and which variables represent risk factors for nonvaccination in people with mental illness.
METHODS
The COVID Ψ Vac study collected routine data on vaccination status, diagnostic groups, sociodemographics, and setting characteristics from in- and day-clinic patients of 10 psychiatric hospitals in Germany in August 2021. Logistic regression modeling was used to determine risk factors for nonvaccination.
RESULTS
Complete vaccination rates were 59% (
CONCLUSIONS
Vaccination rates were lower in hospitalized people with mental illness than in the general population. By targeting at-risk groups with low-threshold vaccination programs in all health institutions they get in contact with, vaccination rates comparable to those in the general population can be achieved.

Identifiants

pubmed: 35762046
doi: 10.1192/j.eurpsy.2022.33
pii: S0924933822000335
pmc: PMC9300974
doi:

Substances chimiques

COVID-19 Vaccines 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e41

Références

World Psychiatry. 2022 Feb;21(1):153-154
pubmed: 35015350
Lancet Psychiatry. 2021 Oct;8(10):854-855
pubmed: 34364405
Lancet Psychiatry. 2021 Sep;8(9):797-812
pubmed: 34274033
Front Psychiatry. 2021 Dec 16;12:805528
pubmed: 34975599
Mol Psychiatry. 2021 Jan;26(1):30-39
pubmed: 32929211
J Am Psychiatr Nurses Assoc. 2020 Mar/Apr;26(2):172-180
pubmed: 30866701
Lancet Psychiatry. 2021 Oct;8(10):860-861
pubmed: 34416185
J R Soc Interface. 2017 Sep;14(134):
pubmed: 28904005
Front Med (Lausanne). 2021 Nov 11;8:761601
pubmed: 34901076
World Psychiatry. 2022 Feb;21(1):124-132
pubmed: 34612005
World Psychiatry. 2017 Feb;16(1):30-40
pubmed: 28127922
Psychiatry Res. 2021 May;299:113856
pubmed: 33740483
World Psychiatry. 2011 Feb;10(1):52-77
pubmed: 21379357
Nervenarzt. 2021 Jun;92(6):562-570
pubmed: 34003321
Acta Psychiatr Scand. 2022 Apr;145(4):416-418
pubmed: 35263443
J Psychiatr Res. 2021 Nov;143:16-20
pubmed: 34438198
World Psychiatry. 2021 Feb;20(1):124-130
pubmed: 33026219
Int J Soc Psychiatry. 2022 Mar 07;:207640221081801
pubmed: 35253527
JAMA Netw Open. 2022 Jan 4;5(1):e2145677
pubmed: 35089352
World Psychiatry. 2011 Jun;10(2):138-51
pubmed: 21633691
World Psychiatry. 2021 Jun;20(2):300-301
pubmed: 34002527
Lancet Psychiatry. 2021 May;8(5):444-450
pubmed: 33548184
Acta Neuropsychiatr. 2021 Oct;33(5):273-276
pubmed: 33998428
Lancet Psychiatry. 2021 Oct;8(10):901-908
pubmed: 34364406

Auteurs

Hauke F Wiegand (HF)

Department of Psychiatry and Psychotherapy, University Medical Center of the Johannes Gutenberg-University, Mainz, Germany.

Birgit Maicher (B)

Department of Psychiatry and Psychotherapy, Carl Gustav Carus University Hospital, Medical Faculty, Technische Universität, Dresden, Germany.

Mike Rueb (M)

Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Munich, Germany.
Institute for Medical Information Processing, Biometry and Epidemiology, LMU Munich, Munich, Germany.
Pettenkofer School of Public Health, LMU Munich, Germany.

Paula Wessels (P)

Department of Psychiatry, Psychosomatics and Psychotherapy, University Hospital of Würzburg, Würzburg, Germany.

Bianca Besteher (B)

Department of Psychiatry and Psychotherapy, Jena University Hospital, Jena, Germany.

Sabine Hellwig (S)

Department of Psychiatry and Psychotherapy, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Andrea Pfennig (A)

Department of Psychiatry and Psychotherapy, Carl Gustav Carus University Hospital, Medical Faculty, Technische Universität, Dresden, Germany.

Henrik Rohner (H)

Department of Psychiatry and Psychotherapy, University Hospital of Bonn, Bonn, Germany.

Stefan Unterecker (S)

Department of Psychiatry, Psychosomatics and Psychotherapy, University Hospital of Würzburg, Würzburg, Germany.

Lars P Hölzel (LP)

Department of Psychiatry and Psychotherapy, University Medical Center of the Johannes Gutenberg-University, Mainz, Germany.
Oberberg Parkklinik Wiesbaden Schlangenbad, Schlangenbad, Germany.

Alexandra Philipsen (A)

Department of Psychiatry and Psychotherapy, University Hospital of Bonn, Bonn, Germany.

Katharina Domschke (K)

Department of Psychiatry and Psychotherapy, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Peter Falkai (P)

Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Munich, Germany.

Klaus Lieb (K)

Department of Psychiatry and Psychotherapy, University Medical Center of the Johannes Gutenberg-University, Mainz, Germany.

Kristina Adorjan (K)

Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Munich, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH